US-based Twin Health Reports Over 90% Success in Reversing Type 2 Diabetes with Digital Twin Technology

Written by Arushi Sharma

Twin Health, a US healthcare company, reports significant success in reversing Type 2 Diabetes using a digital twin technology program.

US-based Twin Health Reports Over 90% Success in Reversing Type 2 Diabetes with Digital Twin Technology
Over 90% of Twin Health program participants achieved diabetes reversal, medication elimination, and weight loss.

Twin Health, a US-based healthcare company, has announced remarkable success in reversing Type 2 diabetes among patients using its diabetes reversal program powered by digital twin technology.

According to the company's press release, more than 90% of patients who participated in the program experienced a reversal of their diabetes condition. Additionally, nearly 92% of participants were able to eliminate all diabetes medications, while also achieving an average weight reduction of 9.1 kg and improvements in liver function.

Dr. Maluk Mohamed, Co-Founder & Global Vice President of Research at Twin Health Inc in San Francisco, and Head of India Operations for Twin Digital Services India, emphasized the transformative potential of their technology in empowering individuals to address the root cause of their health conditions.

Prof. Shashank R Joshi, President of the Indian Academy of Diabetes and a Consultant Endocrinologist at Lilavati Hospitals and Joshi Clinic, highlighted the role of digital twin technology in reversing chronic conditions, reducing complications, and enhancing quality of life.

Dr. Anoop Misra, Chairman at Fortis CDOC Hospital for Diabetes & Allied Sciences, echoed similar sentiments, emphasizing the potential of digital twin technology in achieving remission, reducing medication dependency, and improving overall quality of life for patients.

The Whole-Body Digital Twin developed by Twin Health offers a comprehensive digital representation of an individual's unique metabolism, incorporating over 3,000 data points collected from non-invasive wearable sensors, blood parameters, and personal preferences. This innovative approach holds promise for revolutionizing diabetes management and improving health outcomes for patients worldwide.

Share article